πŸ‡§πŸ‡ͺ Country Profile

Belgium

Fast-growing pharmaceutical trade with Belgium

πŸ‡§πŸ‡ͺ $403M
Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Eurostat records what Belgium imports from India. DGCIS records what India exports to Belgium. Category and product detail from DGCIS.
$403M
Scale
Belgium's healthcare system receives $403M in Indian pharmaceutical products each year β€” affordable, quality medicine.
71%
Medicine
Primarily medicines (71%), supplemented by medicine ingredients and surgical & hospital supplies.
3.0Γ—
Trajectory
Rapid expansion: Belgium's imports of Indian pharmaceutical products have grown 3.0Γ— over the past decade, from $134M to $403M.
Context
Part of India's pharmaceutical supply network across Europe.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Belgium β€” building trade and operational presence.
Export Trend Eurostat CY DGCIS Ch.30
Beyond Finished Medicines DGCIS CY 2014–2025

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $368M (71.2%) Medicine Ingredients $134M (25.9%) Surgical & Hospital Supplies $13.6M (2.6%) Traditional & Herbal $1.4M (0.3%) Vaccines $0.20M (0.0%)
Top Products — FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $161M in active pharmaceutical ingredients and bulk drugs to Belgium in 2025 (India-reported, DGCIS).

Indian Pharma Investment in Belgium Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Belgium: $1.6M across 3 filings (2013-2025).